Department of Molecular Biology, Division of Allergy and Immunology, Paris Lodron University of Salzburg, Austria.
Immunobiology. 2013 Apr;218(4):533-42. doi: 10.1016/j.imbio.2012.06.007. Epub 2012 Jun 26.
Pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are important sensors of microbial products. Although they are referred to as innate immune receptors, they make essential contributions to adaptive immune responses by activating dendritic cells (DCs). Simultaneous activation of DCs via different classes of PRRs provides a powerful tool for inducing strong immune responses. In the present study we investigate the interplay of the NLRs NOD1 and NOD2 and their crosstalk with TLR signaling in terms of DC-activation. We found strong synergistic effects upon treatment with NOD1 and NOD2 ligands combined with the TLR7/8 agonist R848. Simultaneous stimulation of monocyte-derived DCs resulted in highly increased production of IL-1β, IL-23 and SOCS2, a member of the suppressor of cytokine signaling (SOCS) family. Silencing of SOCS2 resulted in enhanced IL-23 expression, indicating that SOCS2 is involved in the regulation of TLR/NOD-dependent cytokine secretion. Finally, we demonstrate that TLR7/8-, NOD1- and NOD2-activated DCs promote CD4+ T cells to release increased amounts of IL-17. These results demonstrate that cooperative activation of DCs with NOD1 and NOD2 agonists and TLR7/8 ligands results in a synergistic release of pro-inflammatory mediators which promote the activation of IL-17-producing T cells.
模式识别受体 (PRRs) ,如 Toll 样受体 (TLRs) 和 NOD 样受体 (NLRs) ,是微生物产物的重要传感器。尽管它们被称为先天免疫受体,但它们通过激活树突状细胞 (DCs) 对适应性免疫反应做出了重要贡献。通过不同类别的 PRRs 同时激活 DCs 提供了诱导强烈免疫反应的有力工具。在本研究中,我们研究了 NLRs NOD1 和 NOD2 及其与 TLR 信号转导的相互作用在 DC 激活方面的作用。我们发现,NOD1 和 NOD2 配体与 TLR7/8 激动剂 R848 联合使用时会产生强烈的协同作用。同时刺激单核细胞衍生的 DCs 会导致 IL-1β、IL-23 和 SOCS2 的产生显著增加,SOCS2 是细胞因子信号转导抑制因子 (SOCS) 家族的一员。SOCS2 的沉默导致 IL-23 表达增强,表明 SOCS2 参与了 TLR/NOD 依赖性细胞因子分泌的调节。最后,我们证明 TLR7/8、NOD1 和 NOD2 激活的 DCs 促进 CD4+ T 细胞释放更多的 IL-17。这些结果表明,NOD1 和 NOD2 激动剂与 TLR7/8 配体协同激活 DCs 会协同释放促炎介质,促进产生 IL-17 的 T 细胞的激活。